These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Lactate infusions: the role of baseline anxiety. Cowley DS; Hyde TS; Dager SR; Dunner DL Psychiatry Res; 1987 Jun; 21(2):169-79. PubMed ID: 3615691 [TBL] [Abstract][Full Text] [Related]
25. Adrenergic status in anxiety disorders: platelet alpha 2-adrenergic receptor binding, blood pressure, pulse, and plasma catecholamines in panic and generalized anxiety disorder patients and in normal subjects. Cameron OG; Smith CB; Lee MA; Hollingsworth PJ; Hill EM; Curtis GC Biol Psychiatry; 1990 Jul; 28(1):3-20. PubMed ID: 2165422 [TBL] [Abstract][Full Text] [Related]
26. Panic disorder, the ventilatory response to carbon dioxide and respiratory variables. Pain MC; Biddle N; Tiller JW Psychosom Med; 1988; 50(5):541-8. PubMed ID: 3141944 [TBL] [Abstract][Full Text] [Related]
27. Plasma lipid levels in patients with panic disorder or agoraphobia. Hayward C; Taylor CB; Roth WT; King R; Agras WS Am J Psychiatry; 1989 Jul; 146(7):917-9. PubMed ID: 2742017 [TBL] [Abstract][Full Text] [Related]
28. Relationship of urinary free cortisol levels in patients with panic disorder to symptoms of depression and agoraphobia. Kathol RG; Noyes R; Lopez AL; Reich JH Psychiatry Res; 1988 May; 24(2):211-21. PubMed ID: 3406239 [TBL] [Abstract][Full Text] [Related]
29. The dexamethasone suppression test in panic disorder and agoraphobia. Curtis GC; Cameron OG; Nesse RM Am J Psychiatry; 1982 Aug; 139(8):1043-6. PubMed ID: 7091428 [TBL] [Abstract][Full Text] [Related]
30. Dehydroepiandrosterone-sulfate/cortisol ratio in panic disorder. Fava M; Rosenbaum JF; MacLaughlin RA; Tesar GE; Pollack MH; Cohen LS; Hirsch M Psychiatry Res; 1989 Jun; 28(3):345-50. PubMed ID: 2527376 [TBL] [Abstract][Full Text] [Related]
33. Dexamethasone suppression test in patients with panic attacks. Bridges M; Yeragani VK; Rainey JM; Pohl R Biol Psychiatry; 1986 Jul; 21(8-9):853-5. PubMed ID: 3730467 [No Abstract] [Full Text] [Related]
34. Platelet serotonin uptake in panic disorder: comparison with normal controls and the effect of treatment. Norman TR; Gregory MS; Judd FK; Burrows GD; McIntyre IM Aust N Z J Psychiatry; 1988 Dec; 22(4):390-5. PubMed ID: 2907288 [TBL] [Abstract][Full Text] [Related]
35. A kinetic analysis of platelet monoamine oxidase activity in patients with panic attacks. Norman TR; Acevedo A; McIntyre IM; Judd FK; Burrows GD J Affect Disord; 1988; 15(2):127-30. PubMed ID: 2975682 [TBL] [Abstract][Full Text] [Related]
36. Differential diagnosis and treatment of panic attacks and phobic states. Liebowitz MR; Klein DF Annu Rev Med; 1981; 32():583-99. PubMed ID: 7013690 [TBL] [Abstract][Full Text] [Related]
37. HLA system and panic attacks. Cottraux J; Gebührer L; Bardi R; Betuel H Biol Psychiatry; 1989 Feb; 25(4):505-8. PubMed ID: 2930815 [No Abstract] [Full Text] [Related]
38. HPA axis disturbance and treatment outcome in panic disorder. Coryell W; Noyes R Biol Psychiatry; 1988 Nov; 24(7):762-6. PubMed ID: 3067754 [TBL] [Abstract][Full Text] [Related]
39. Autonomic characteristics of agoraphobia with panic attacks. Roth WT; Telch MJ; Taylor CB; Sachitano JA; Gallen CC; Kopell ML; McClenahan KL; Agras WS; Pfefferbaum A Biol Psychiatry; 1986 Oct; 21(12):1133-54. PubMed ID: 3756263 [TBL] [Abstract][Full Text] [Related]
40. Panic attacks. A review of treatments and pathogenesis. Grunhaus L; Gloger S; Weisstub E J Nerv Ment Dis; 1981 Oct; 169(10):608-13. PubMed ID: 6116741 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]